相关实验视频

Updated: Jun 10, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

瘤微环境作为皮肤T细胞淋巴瘤的治疗目标

Louis Boafo Kwantwi^1,2,3, Steven T Rosen^2,4, Christiane Querfeld^1,2,4,5

¹Department of Pathology, City of Hope Medical Center, Duarte, CA 91010, USA.

|October 16, 2024

概括

皮肤T细胞淋巴瘤 (CTCL) 是一种复杂的癌症. 向瘤微环境,恶性细胞操纵以逃避免疫力,为先进的CTCL提供了有希望的新治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
皮肤病学皮肤病学

背景情况:

皮肤T细胞淋巴瘤 (CTCL),包括真菌菌菌病和塞萨里综合征,是各种各样的非霍奇金淋巴瘤.
尽管治疗取得了进展,但由于缺乏了解的机制,一些患者仍会进入晚期.
瘤微环境越来越被认为是CTCL进展的关键因素.

研究的目的:

突出最近对CTCL瘤微环境中的驱动疾病进展的因素的见解.
讨论针对CTCL瘤微环境的新兴策略,以提高治疗疗效.

主要方法:

对CTCL病原和瘤微环境的当前文献的综述.
分析恶性T细胞影响微环境的机制.
探索针对瘤微环境组件的治疗策略.

主要成果:

恶性T细胞积极塑造瘤微环境以抑制抗瘤免疫力.
关键机制包括改变的细胞因子模式,遗传变化,免疫检查点分子和免疫抑制细胞.
这些修改促进了Th2扭曲的反应,促进了瘤的进展.

结论:

瘤微环境在晚期CTCL的进展中起着至关重要的作用.
向瘤微环境是一个有希望的治疗途径,可以改善CTCL患者的治疗结果.

关键词:

塞萨里综合征是什么意思皮肤T细胞淋巴瘤细胞因子细胞因子遗传变化遗传变化免疫检查点的检查点.菌菌病菌病菌病瘤微环境是一个微环境.

更多相关视频

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...